BACE2 and melanoma: More recently, BACE2 have been reported to be highly expressed also in other types of tumors, such as glioma [45, 46] and melanoma [44], where different mechanisms have been revealed to explain how processing of amyloidogenic proteins can drive tumor growth and promote drug resistance.